Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -1.79
- Piotroski Score 5.00
- Grade Buy
- Symbol (ENZ)
- Company Enzo Biochem, Inc.
- Price $1.13
- Changes Percentage (-1.32%)
- Change -$0.02
- Day Low $1.09
- Day High $1.13
- Year High $1.50
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment provides molecular and other clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. It operates a full-service clinical laboratory in Farmingdale, New York; a network of 30 patient service centers in New York and New Jersey; and a free-standing STAT' or rapid response laboratories in New York City and Connecticut, as well as a full-service phlebotomy center and an in-house logistics department. The Therapeutics segment develops novel approaches in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. It markets its products and services through its direct sales force and a network of distributors in the United States and internationally. The company was founded in 1976 and is headquartered in New York, New York.
- Last Earnings N/A
- Ex-Dividend for 5/16 Dividend 06/29/1995
- Dividend Payable N/A
- Today N/A
- Next Earnings (Estimated) 11/03/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.47
- Trailing P/E Ratio -2.4
- Forward P/E Ratio -2.4
- P/E Growth -2.4
- Net Income $20.29 M
Income Statement
Quarterly
Annual
Latest News of ENZ
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Timberwolves agree to trade Towns to Knicks for Randle, DiVincenzo, 1st-rounder, AP source says
The Minnesota Timberwolves are trading Karl-Anthony Towns to the New York Knicks for Julius Randle, Donte DiVincenzo, and a first-round draft pick....
By AP NEWS | 18 hours ago -
Exclusive-Shanghai, Shenzhen to lift key home purchase curbs to boost market, sources say
Shanghai and Shenzhen are set to lift home purchase restrictions to attract buyers and revive their real estate markets. The changes aim to allow people from all over China to buy homes in these citie...
By Yahoo! Finance | 1 day ago -
Gladiator II: Denzel Washington and Paul Mescal Form an Uneasy Alliance in Thrilling New Trailer
Paramount Pictures released a new trailer for Ridley Scott's Gladiator sequel starring Paul Mescal. The film follows Lucius as he navigates power struggles in ancient Rome, seeking vengeance and resto...
By PEOPLE.com | 5 days ago
